These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 29629730

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
    Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M.
    Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.
    Riedl MA, Banerji A, Manning ME, Burrell E, Joshi N, Patel D, Machnig T, Tai MH, Watson DJ.
    Orphanet J Rare Dis; 2018 Oct 12; 13(1):180. PubMed ID: 30314518
    [Abstract] [Full Text] [Related]

  • 50. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.
    Zanichelli A, Azin GM, Cristina F, Vacchini R, Caballero T.
    Orphanet J Rare Dis; 2018 Apr 10; 13(1):51. PubMed ID: 29631595
    [Abstract] [Full Text] [Related]

  • 51. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
    Greve J, Hoffmann TK, Schuler P, Lang S, Chaker A, Bas M.
    Int J Dermatol; 2011 Oct 10; 50(10):1294-5. PubMed ID: 21950301
    [Abstract] [Full Text] [Related]

  • 52. Safety and efficacy of icatibant self-administration for acute hereditary angioedema.
    Boccon-Gibod I, Bouillet L.
    Clin Exp Immunol; 2012 Jun 10; 168(3):303-7. PubMed ID: 22519593
    [Abstract] [Full Text] [Related]

  • 53. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N, Craig TJ.
    Transfusion; 2014 Nov 10; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G, Craig T.
    Expert Rev Clin Immunol; 2015 Mar 10; 11(3):319-27. PubMed ID: 25669442
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The relationship between anxiety and quality of life in children with hereditary angioedema.
    Kessel A, Farkas H, Kivity S, Veszeli N, Kőhalmi KV, Engel-Yeger B.
    Pediatr Allergy Immunol; 2017 Nov 10; 28(7):692-698. PubMed ID: 28692169
    [Abstract] [Full Text] [Related]

  • 59. Hereditary angioedema: new hopes for an orphan disease.
    Reshef A, Leibovich I, Goren A.
    Isr Med Assoc J; 2008 Dec 10; 10(12):850-5. PubMed ID: 19160940
    [Abstract] [Full Text] [Related]

  • 60. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
    Prescrire Int; 2010 Nov 10; 19(110):245-7. PubMed ID: 21284353
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.